Cigarette smoking increases risk of Barretts esophagus: an analysis of the Barretts and Esophageal Adenocarcinoma Consortium
With tirzepatide (Zepbound, Mounjaro), patients lose an average of 15-22% of body weight (37-55 pounds for a 250-pound person) over 18-20 months
This biogenic program upregulates mitochondrial transcription factor A (TFAM) and electron transport chain (ETC) proteins, thereby increasing oxygen consumption and ATP/ADP ratios (Kang et al., 2015)
Research shows that oral GLP-1 medications, like oral semaglutide, can produce metabolic results and weight loss similar to injectable GLP-1s when taken at effective doses and with good adherence
The generic liraglutide includes a Boxed Warning to advise health care professionals and patients about the increased risk for thyroid C-cell tumors
Nano-mechanical immunoengineering: nanoparticle elasticity reprograms Tumor-Associated macrophages via Piezo1